Aadi Bioscience, Inc.
USD2.05
-0.05 (-2.38%)
CEO
David J. Lennon
IPO Date
2018-02-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.15
Prev. Close
$2.10
Day Low
$2.02
Day High
$2.19
52W Low
$1.21
52W High
$3.81
Market Cap
$0.09B
Volume
0.06M
| -1.3 |
| 31 Dec 2023 | FY | -112.4% | -270.0% | -62.5% | -49.7% | 0.01 | 4.72 | -0.8 |
| 31 Dec 2022 | FY | -123.4% | -397.7% | -38.2% | -32.8% | 0.01 | 9.56 | -4.8 |
| 31 Dec 2021 | FY | -1656.3% | -9829.5% | -80.7% | -69.7% | 0.00 | 9.90 | -1.9 |
| 31 Dec 2020 | FY | -2.9% | -23.9% | 28.0% | -18.5% | -0.82 | 0.62 | -88.1 |
| 31 Dec 2019 | FY | -1377.2% | -1636.2% | 134.8% | -73.6% | -0.93 | 0.64 | -5.7 |
| -1.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -11.3% | -10.6% | 0.00 | 16.76 | -1.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -30.6% | -29.1% | 0.00 | 20.41 | -0.6 |
| 31 Mar 2025 | Q1 | 89.4% | 1021.9% | 32.9% | 31.2% | 0.00 | 18.95 | 0.2 |
| 31 Dec 2024 | Q4 | -109.1% | -252.4% | -34.8% | -26.0% | 0.02 | 3.59 | -1.2 |
| 30 Sept 2024 | Q3 | -49.8% | -174.0% | -18.2% | -14.6% | 0.01 | 4.89 | -1.1 |
| 30 Jun 2024 | Q2 | -124.5% | -236.0% | -18.5% | -14.4% | 0.01 | 4.20 | -0.7 |
| 31 Mar 2024 | Q1 | -166.1% | -341.7% | -20.2% | -16.5% | 0.01 | 5.16 | -0.9 |
| 31 Dec 2023 | Q4 | -116.5% | -257.2% | -15.5% | -12.3% | 0.01 | 4.72 | -0.8 |